David Rolfe - Wedgewood Partners
Holding/activity history for Edwards Lifesciences Corp. (EW)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2023 Q4 | 250,652 | 4.55 | Add 29.34% | 1.03 | $86.26 |
| 2023 Q3 | 193,797 | 3.21 | Reduce 38.51% | 2.01 | $69.28 |
| 2023 Q2 | 315,173 | 4.79 | Reduce 4.51% | 0.23 | $94.33 |
| 2023 Q1 | 330,070 | 4.63 | Reduce 1.11% | 0.05 | $82.73 |
| 2022 Q4 | 333,760 | 4.57 | Add 0.64% | 0.03 | $74.61 |
| 2022 Q3 | 331,627 | 5.16 | Reduce 2.66% | 0.14 | $82.63 |
| 2022 Q2 | 340,689 | 5.60 | Reduce 4.89% | 0.29 | $95.09 |
| 2022 Q1 | 358,220 | 5.95 | Add 1.44% | 0.08 | $117.72 |
| 2021 Q4 | 353,149 | 6.07 | Reduce 25.28% | 2.05 | $129.55 |
| 2021 Q3 | 472,627 | 7.55 | Reduce 2.26% | 0.17 | $113.21 |
| 2021 Q2 | 483,536 | 7.26 | Reduce 5.91% | 0.46 | $103.57 |
| 2021 Q1 | 513,888 | 6.62 | Reduce 13.63% | 1.04 | $83.64 |
| 2020 Q4 | 594,956 | 8.07 | Reduce 5.82% | 0.50 | $91.23 |
| 2020 Q3 | 631,718 | 7.97 | Reduce 5.51% | 0.46 | $79.82 |
| 2020 Q2 | 668,542 | 7.83 | Add 181.85% | 5.05 | $69.11 |
| 2020 Q1 | 237,200 | 8.48 | Reduce 36.59% | 4.89 | $188.62 |
| 2019 Q4 | 374,062 | 8.85 | Reduce 21.87% | 2.48 | $233.29 |
| 2019 Q3 | 478,789 | 9.33 | Reduce 7.98% | 0.81 | $219.91 |
| 2019 Q2 | 520,293 | 8.14 | Reduce 21.27% | 2.20 | $184.74 |
| 2019 Q1 | 660,819 | 9.23 | Reduce 19.52% | 2.24 | $191.33 |
| 2018 Q4 | 821,132 | 8.35 | Add 0.27% | 0.02 | $153.17 |
| 2018 Q3 | 818,960 | 7.15 | Reduce 8.13% | 0.63 | $174.10 |
| 2018 Q2 | 891,410 | 6.55 | Reduce 21.28% | 1.77 | $145.57 |
| 2018 Q1 | 1,132,341 | 7.27 | Reduce 15.48% | 1.33 | $139.52 |
| 2017 Q4 | 1,339,762 | 6.11 | Reduce 0.24% | 0.01 | $112.71 |
| 2017 Q3 | 1,343,047 | 5.01 | Add 55.92% | 1.80 | $109.31 |
| 2017 Q2 | 861,348 | 3.12 | Reduce 24.25% | 1.00 | $118.24 |
| 2017 Q1 | 1,137,072 | 2.75 | Buy | 2.75 | $94.07 |